IPP Bureau
Gujarat Kidney and Super Speciality to file IPO at Rs.108- Rs.114 per share
By IPP Bureau - December 17, 2025
The company operates a chain of mid-sized multi-speciality hospitals
Minghui Pharmaceutical gets FDA green light for Phase III trials of its therapy in thyroid eye disease
By IPP Bureau - December 17, 2025
The upcoming trials will evaluate both active and chronic TED in randomized, double-blind, placebo-controlled studies
Ascletis Pharma reports positive Phase I results for oral IL-17 inhibitor
By IPP Bureau - December 17, 2025
The randomized, double-blind, placebo-controlled single ascending dose (SAD) study evaluated safety, tolerability, pharmacokinetics, and target engagement in 46 healthy participants
Vanda Pharmaceuticals seeks FDA nod for breakthrough psoriasis drug
By IPP Bureau - December 17, 2025
Imsidolimab, an IgG4 IL-36 receptor antagonist, works by inhibiting IL-36 receptor signaling, directly addressing the deficiency in the IL-36RA regulator common in GPP patients
FDA nod to first oral single-dose treatment for gonorrhea
By IPP Bureau - December 16, 2025
The approval of Nuzolvence (zoliflodacin) follows a collaborative development effort with the Global Antibiotic Research and Development Partnership
Accenture invests in Ryght AI to revolutionize clinical trials
By IPP Bureau - December 16, 2025
Ryght AI tackles these hurdles with its AI Site Twin platform
FDA accepts Sentynl Therapeutics CUTX-101 NDA resubmission
By IPP Bureau - December 16, 2025
If approved, CUTX-101 will be the first and only FDA approved treatment available for Menkes disease
Ind-Swift Laboratories receives GMP compliance certificate from NNGYK-Hungary
By IPP Bureau - December 16, 2025
The said certificate is valid for a period of 3 years and opens up the European and other markets for the company's products
KIMS Hospital Bengaluru commences operations at PES University campus
By IPP Bureau - December 16, 2025
The state-of-the-art facility is a 350-bedded, multi-specialty tertiary care hospital
Shelter Pharma launches D3 cure capsules
By IPP Bureau - December 16, 2025
This launch is part of the company's strategy to expand its nutraceutical portfolio
Biocon launches its Glucagon-like Peptide-1, Liraglutide, in the Netherlands
By IPP Bureau - December 16, 2025
Godavari Biorefineries ED Sangeeta Srivastava named BRSI Honorary Fellow
By IPP Bureau - December 16, 2025
Dr Srivastava was selected by an expert jury in recognition of her sustained contributions to renewable chemicals, industrial biotechnology and bioprocess innovation
Pharma overhaul: EMA hails “Once-in-a-Generation” reform
By IPP Bureau - December 16, 2025
The reform is set to modernise how medicines are developed, authorised, and made available across the EU
Sanofi flags delay in FDA review of Tolebrutinib for progressive multiple sclerosis
By IPP Bureau - December 16, 2025
